Home
overview

SMi proudly presents its inaugural Drug Discovery conference in London, 2017!

In recent years, the Pharmaceutical/Biotech industry has undergone radical changes which have increased our understanding of drug discovery and development, however there are still many hurdles that the industry face.

The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions of dollars. SMi's inaugural Drug Discovery conference 27th-28th March 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.

Our Drug Discovery conference highlights the latest scientific breakthroughs and new approaches that are driving the success of the drug discovery industry. The conference explores innovative technologies and approaches that can be used to overcome drug development challenges and bring together industry leaders who will highlight future opportunities for novel therapeutic discovery.
 

Now is the time to invest and join us next March for SMi's inaugural Drug Discovery conference!

  

  • Hear AstraZeneca discuss stem cells, precise-genome editing (CRISPR/Cas9) for target validation phenotypic screening
  • Novartis optimise the success of phenotyping screening Is translational medicine capable of increasing the success rate in the pharmaceutical industry? Answers from Takeda
  • Gain insights into receptor activation from agonist & antagonist structures with Merck
  • AbbVie apply enabling chemistry technology to the acceleration of the drug discovery process

Ariad Pharmaceuticals; AstraZeneca; atugen AG; BioFocus Plc; Biotech; Biowisdom; Bristol-Myers Squibb Company; Centre For The Economics Of Mental Health Institute Of Psychiatry; Devgen; ESBA Tech AG; Exelixis; G E Healthcare; Gendaq; GeneData; GeneTrove; GenKyoTex; GlaxoSmithKline; Hybridgenics; Incyte Genomics Limited; Kinetek Pharmaceuticals; Lion Bioscience; LION Bioscience AG; Lovells; Millennium Pharmaceuticals; None; Novartis; Oxford BioMedica (U K) Limited; Oxrford Biomedica; Personal Chemistry Ltd; Pfizer; Pharma Matters; Phase 1 Molecular Toxicology; Quintiles (UK) Ltd; Sangamo Biosciences; Tabriz Consulting Ltd ;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Werngard  Czechtizky

Werngard Czechtizky, Section Head, Medicinal Chemistry, Sanofi-Aventis

9:10 Transforming and Translating Drug Discovery – Use of the CRISPR/Cas9 Technology in Target Discovery, Hit Finding and Translational Studies

Lorenz Mayr

Lorenz Mayr, Vice President and Global Head, Reagents & Assay Development, AstraZeneca

  • Overview of PGE and introduction to CRISPR/Cas9
  • technology
  • Applications in target fi nding, hit & lead discovery,
  • efficacy & safety models
  • AstraZeneca’s unique approach towards innovation
  • & collaboration
  • Case studies from AstraZeneca’s drug discovery programmes
  • Future outlook of PGE for drug discovery & therapeutic applications
  •  

     

    9:55 Quality by design in support of early discovery

    Stephen  Pickett

    Stephen Pickett, Senior Scientific Investigator, GSK Fellow, GlaxoSmithKline

  • Designing a compound collection to support different screening paradigms
  • Maximizing information from high throughput and phenotypic screening
  • Predictive modeling to support lead generation and optimization
     
  • 10:35 Morning Coffee

    11:05 Orion: CADD reimagined as a cloud enterprise

    Anthony Nicholls

    Anthony Nicholls, President, CEO, OpenEye Scientific Software

  • Orion is OpenEye’s reimagining of all the elements of CADD conducted entirely within a cloud service, in our case Amazon Web Services (AWS), delivered as either a hosted system or an in-house VPC solution
  • As a 'cloud native' platform Orion completely automates and manages access to large scale AWS processing and storage
  • In-cloud facilities include molecular design, 3D visualization, data analysis, results/method sharing and project organization
  • All of OpenEye science is included, enabling users to construct innovative workflows with Floe, our pipelining tool
  • As an open platform Orion allows for straightforward integration of third-party code (customer, academic, vendor)
  • Interaction with Orion is via a simple webpage, deliverable on any internet-enabled device
  • 11:45 Fragments for drug discovery and chemical biology

  • Recent experience with conventional (kinases) and more challenging (Bcl-2 and Mcl-1) targets
  • Current topics in fragment methods - 3D fragments,off-rate screening
  • Fragments for chemical biology (antimicrobial target ID and activating industrial enzymes)
  • Roderick  Hubbard

    Roderick Hubbard , Senior Fellow, Vernalis Research Ltd

    12:25 Networking Lunch

    13:25 Structure based drug discovery on membrane protein targets: New developments and advancements

    Michael Hennig

    Michael Hennig, CEO, leadXpro AG

  • Structure based drug discovery for soluble proteins is routinely used in pharmaceutical industry, but transmembrane proteins are still challenging
  • Progress in membrane protein expression, purifi cation and solubilization as well as use of serial crystallography at synchrotron and Free Electron Laser (FEL)
  • Recent developments on single particle cryo-Electron
  • Microscopy for high resolution structure determination
  • Outline of new opportunities for hit and lead discovery using information derived from biophysical methods and structures of membrane protein drug targets

     

  • 14:05 Large scale analysis of a pharmaceutical company database to inform future drug discovery

    Lewis Vidler

    Lewis Vidler, Research Scientist, Eli Lilly & Co

  • Analysis of the Lilly database will be presented with a particular focus on compounds showing promiscuous or assay interfering behaviour
  • Looking at an approach involving compound fragmentation and analysis of molecules containing the fragments
  • Identifying fragments enriching for compound promiscuity, instability and cytotoxicity
  • 14:45 Afternoon Tea

    15:15 Approaches to identify small molecule binders and more

    Marta Westwood

    Marta Westwood, Senior Scientist, UCB Pharma Limited

  • Understanding the target protein
  • Molecular dynamics and use of antibodies as tools to sample protein conformations
  • Technologies to detect conformational change in the target protein upon small molecule binding
  • 15:55 Phenotypic screening in drug discovery

    Ulrich Schopfer

    Ulrich Schopfer, Head of Integrated Target & Lead Discovery, Novartis

  • Overcoming the considerable challenges with phenotypic screening
  • Optimising success factors
  • How Novartis’s efforts in phenotypic screening have influenced our approach to drug discovery
  • 16:35 New approaches in lead generation: Towards drugs for every targets

  • Limitations of current hit finding strategies and small molecule collections
  • New business models, partnerships, consortia, open innovation in lead generation
  • Addressing ‘intractable’ targets with New modalities and novel technologies
  • A new lead generation paradigm with synthetic biology, drug conjugates, and novel mode of actions
  • Patrick Jimonet

    Patrick Jimonet, Manager, Sanofi

    Eric Valeur

    Eric Valeur, Associate Director, New Modalities & Lead Generation , AstraZeneca

    17:15 Chairman’s Closing Remarks and Close of Day One

    Werngard  Czechtizky

    Werngard Czechtizky, Section Head, Medicinal Chemistry, Sanofi-Aventis

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Guido Hanauer

    Guido Hanauer, Scientific Director Translational Medicine, Takeda

    9:10 Is translational medicine capable to increase success rate in the pharmaceutical industry?

    Guido Hanauer

    Guido Hanauer, Scientific Director Translational Medicine, Takeda

  • Tasks of translational medicine
  • Tools used in translational medicine
  • Critical evaluation of these tools
  • Reinventing translational medicine
  • 9:50 Image-based phenomics for drug discovery

    Steffen Jaensch

    Steffen Jaensch, Senior Scientist, Janssen Pharmaceutica NV

  • Exploring new technologies that allow for acquisition of high-dimensional biological data
  • Phenomics: next generation phenotypic screening methods for the drug discovery pipeline
  • Applying phenomic analysis to uncover compound cellular mechanism of action
  •  

    10:30 Morning Coffee

    11:00 Advancing structural information of ligand-receptor complexes

    Matthias Frech

    Matthias Frech, Director Molecular Interactions and Biophysics, Merck KGaA

  • Insights into receptor activation from agonist and antagonist structures
  • Probabilistic outcomes of molecular recognition,limitations to models and matching unique events
  • Controlling lypophilicity and MW to optimise molecular recognition
  • High-quality 3D models of GPCRs and to perform molecular dynamics simulations
  • 11:40 Application of enabling chemistry technology to the acceleration of the drug discovery process

    Stevan Djuric

    Stevan Djuric, Senior Director Discovery Chemistry and Technology, AbbVie

    Flow chemistry platforms including:

  • Compound library synthesis using segmented flow,
  • photochemistry
  • electrochemistry
  • high temperature chemistry to access novel heterocycles


    MS based analytical technologies applied to:

  • Drug Distribution
  • Product Protection
     
  • 12:20 Networking Lunch

    13:20 Macrocycles as new therapeutic modalities for challenging targets in drug discovery

    Steffen Weinbrenner

    Steffen Weinbrenner, Head Drug Discovery, Polyphor Ltd

    • Peptidic Macrocycles – from Discovery to clinics
    • Design of Non-peptidic Macrocycles for oral applications
    • Chemical Optimization of Macrocycles – a case study
     

    14:00 Determination of high-resolution X-ray structures of G protein-coupled receptors (GPCRs) to discover new drug lead compounds

    Nigel  Swain

    Nigel Swain, Senior Medicinal Chemist , Heptares Therapeutics

  • Combination of technologies that has the potential to accelerate the delivery of structural information for drug discovery efforts
  • Case study: StaR® protein and structure-based drug design platform
  • What the future holds for GPCR structure based drug discovery
  • 14:40 Afternoon Tea

    15:10 Expanding the chemical space using NPs: Internal approaches & collaborations

    Werngard  Czechtizky

    Werngard Czechtizky, Section Head, Medicinal Chemistry, Sanofi-Aventis

  • Overview on Sanofi natural products
  • NP based collaborations
  • Toxins – from isolation to synthesis and structure elucidation
  • TAFIa inhibition – converting a NP to a potent SM lead compound
  • 15:50 Multi-Organ-Chip developments: Towards a paradigm shift in drug development?

    Reyk Horland

    Reyk Horland, Head of Business Development, Tissuse G Mb H

  • ‘Human-on-a-chip’ technology allows us to closely study organoid interaction
  • Allows more representative drug toxicity and efficacy screening. Could this be the end of preclinical trials as we know them?
  • Closing the gap between in vivo and in vitro; the importance of highly physiologically relevant cultures and microenvironments

     
  • 16:30 Chairman’s Closing Remarks and Close of Day Two

    Guido Hanauer

    Guido Hanauer, Scientific Director Translational Medicine, Takeda

    +

    FEATURED SPEAKERS

    Guido Hanauer

    Guido Hanauer

    Scientific Director Translational Medicine, Takeda
    Lorenz Mayr

    Lorenz Mayr

    Vice President and Global Head, Reagents & Assay Development, AstraZeneca
    Matthias Frech

    Matthias Frech

    Director Molecular Interactions and Biophysics, Merck KGaA
    Stevan Djuric

    Stevan Djuric

    Senior Director Discovery Chemistry and Technology, AbbVie

    Anthony Nicholls

    President, CEO, OpenEye Scientific Software
    Anthony Nicholls

    Eric Valeur

    Associate Director, New Modalities & Lead Generation , AstraZeneca
    Eric Valeur

    Guido Hanauer

    Scientific Director Translational Medicine, Takeda
    Guido Hanauer

    Lewis Vidler

    Research Scientist, Eli Lilly & Co
    Lewis Vidler

    Lorenz Mayr

    Vice President and Global Head, Reagents & Assay Development, AstraZeneca
    Lorenz Mayr

    Marta Westwood

    Senior Scientist, UCB Pharma Limited
    Marta Westwood

    Matthias Frech

    Director Molecular Interactions and Biophysics, Merck KGaA
    Matthias Frech

    Michael Hennig

    CEO, leadXpro AG
    Michael Hennig

    Nigel Swain

    Senior Medicinal Chemist , Heptares Therapeutics
    Nigel  Swain

    Patrick Jimonet

    External Innovation Drug Discovery, Sanofi
    Patrick Jimonet

    Reyk Horland

    Head of Business Development, Tissuse G Mb H
    Reyk Horland

    Roderick Hubbard

    Senior Fellow, Vernalis Research Ltd
    Roderick  Hubbard

    Steffen Jaensch

    Senior Scientist, Janssen Pharmaceutica NV
    Steffen Jaensch

    Steffen Weinbrenner

    Head Drug Discovery, Polyphor Ltd
    Steffen Weinbrenner

    Stephen Pickett

    Senior Scientific Investigator, GSK Fellow, GlaxoSmithKline
    Stephen  Pickett

    Stevan Djuric

    Senior Director Discovery Chemistry and Technology, AbbVie
    Stevan Djuric

    Ulrich Schopfer

    Head of Integrated Target & Lead Discovery, Novartis
    Ulrich Schopfer

    Werngard Czechtizky

    Section Head, Medicinal Chemistry, Sanofi-Aventis
    Werngard  Czechtizky

    Sponsors and Exhibitors

    Official Media Partner

    Official Publication

    Supporters

    Workshops

    New Approaches in lead generation: Towards drugs for every targets?
    Workshop

    New Approaches in lead generation: Towards drugs for every targets?

    Holiday Inn Kensington Forum
    29th March 2017
    London, United Kingdom

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    2017 Delegate Profile List

    Download

    Interview with Lewis Vidler, Research Scientist, Eli Lilly

    Download

    Interview with Patrick Jimonet, Sanofi

    Download

    Sponsors and Exhibitors


    Cisbio Bioassays

    Sponsors and Exhibitors
    http://www.cisbio.com/

    Cisbio Bioassays develops and markets products and technologies used for in vitro diagnostics and drug discovery. With its proprietary technology, HTRF®, the company is a leader in homogeneous fluorescence detection methods, and offers first class assays and services for drug discovery researchers. In addition, Cisbio Bioassays provides a broad range of immunoassays for in vitro diagnostics, mainly tailored for cancerous pathologies, as well as metabolic and auto-immune diseases. Based in Codolet, France, Cisbio Bioassays owns facilities in Bedford, MA, U.S.A., Shanghai, China, and Tokyo, Japan, and also markets its global offer through a network of distributors.


    OpenEye Scientific Software

    Sponsors and Exhibitors
    http://www.eyesopen.com/

    OpenEye has built a solid reputation as a scientific leader in the field of molecular design based on two decades of delivering useful applications and programming toolkits. Our scientific approach has focussed on the power of molecular 3D structure to inform and guide, in particular via the concept of shape similarity. We have changed industry perception of what is possible with the speed, robustness and scalability of our tools and have recently built these into a ground-up, cloud-native platform, Orion. Combining unlimited computation and storage with powerful tools for data sharing, visualization and analysis in an open development platform, Orion offers unprecedented capabilities for drug discovery and optimization.

    Media Partners


    Chimica Oggi – Chemistry Today

    Official Media Partner
    http://www.teknoscienze.com

    Chimica Oggi – Chemistry Today, the international journal of Fine Chemicals, Applied Chemistry and Biotechnology, is a peer reviewed, bimonthly journal, specialized in fine chemistry, pharmaceuticals, analytical technologies, chemical engineering and biotechnology of the TKS – TeknoScienze Publisher. Founded in 1983 Chimica Oggi – Chemistry Today soon became a leading journal in linking industry and academia and gained an immediate appreciation.

    Media Partners


    International Journal of Medical Engineering and Informatics

    Official Publication
    http://www.inderscience.com/ijmei

    IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.


    International Journal of Biomedical Engineering and Technology

    Official Publication
    http://www.inderscience.com/ijbet

    IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).


    International Journal of Computational Biology and Drug Design

    Official Publication
    http://www.inderscience.com/ijcbdd

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


    Int. J. of Biotechnology

    Official Publication
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    International Journal of Functional Informatics and Personalised Medicine

    Official Publication
    www.inderscience.com/ijfipm

    Functional informatics and personalised medicine in the new era of biomedical sciences and computational sciences are interactive disciplines that hold great promise for the advancement of cutting-edge research and development in biomedical informatics and pharmaceutical sciences. IJFIPM is dedicated to promoting the research, education and awareness of functional informatics and personalised medicine, and provides a common platform for the cross-fertilisation of ideas by bridging important and complementary disciplines into an interactive and attractive forum.

    Media Partners


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    RareBase

    Supporters
    http://www.rarebase.co.uk

    The RareBase Networking Portal links people and companies throughout the world with an interest in rare and paediatric diseases.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    BioChem Adda

    Supporters
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    evvnt Ltd

    Supporters
    http://www.evvnt.com

    evvnt enables people all over the world to fill their events utilising the most effective event listing sites on the web. Every minute, with little more than a click, more events and conferences appear in listings, in search engines and on mobile - discoverable by both category and location. With next to no effort customers of evvnt get better attendance, while consumers find events they previously had no idea existed. To date customers in 70 countries worldwide have submitted over 500,000 thousand event listings, created over 300,000 live links, and generated 1 million clicks to ticketing and registration pages. Learn more at www.evvnt.com


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Labiotech.eu

    Supporters
    http://labiotech.eu

    Labiotech.eu is the leading digital media covering the European Biotech industry. It is used by over 55000 people monthly to keep a watch on the business and innovations of biotechnologies.


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.